Aspinall et al., “Lipopolysaccharides of Campylobacter jejuni Serotype O: 19: Structures of Core Oligosaccharide Regions from the Serostrain and Two Bacterial Isolates from Patients with the Guillain-Barré Syndrome” Biochemistry, 33:241-249 (1994b). |
Aspinall et al., “Lipopolysaccharides of Campylobacter jejuni Serotype O: 19: Antigen Chains from the Serostrain and Two Bacterial Isolates from Patients with the Guillain-Barré Syndrome” Biochemistry, 33:250-255 (1994c). |
Aspinall, et al. “ Chemical Structures of the Core Regions of Campylobacter Jejuni Serotypes 0:1, 0:4, 0:23, and 0:36 Lipopolysaccharides,” European Journal of Biochemistry, vol. 213, No. 3, pp. 1017-1027, (May 1993). |
Aspinall. et al. “Lipopolysaccharides from Campylobacter Jejuni Associated with Guillain-Barré Syndrome Patients Mimic Human Gangliosides in Structure,” Infection and Immunity, vol. 62, No. 5, pp. 2122-2125, (May 1994). |
Belunis et al., “Biosynthesis of Endotoxin” J. Biol. Chem., 267: 9988-9997 (1992). |
Gaudino et al., “A Novel and Efficient Synthesis of Neolacto Series Gangliosides 3′-nLM1 and 6′-nLM1 ” J. Am. Chem. Soc., 116: 1149-1150 (1994). |
Gilbert et al., “Cloning of the Lipooligosaccharide α-2,3-Sialyltransferase from the Bacterial Pathogens Neisseria Meningitidis and Neisseria Gonorrhoeae”, Journal of Biological Chemistry, vol. 271, No. 45, pp. 28271-28276, The American Society for Biochemistry and Molecular Biology, Inc., USA, (Nov. 6, 1996). |
Gilbert, et al., “Biosynthesis of Ganglioside Mimics in Campylobacter Jejuni OH4384,” The Journal of Biolofical Chemistry, vol. 275, No. 6, pp. 3896-3906, The American Society for Biochemistry and Molecular Biology, Inc., USA, (Feb. 11, 2000). |
Ito et al., “Synthesis of Bioactive Sialosides” Pure Appl. Chem., 65: 753 (1993). |
Kuroki, “Campylobacter jejuni Strains from Patients with Guillain-Barré Syndrome Belong Mostly to Penner Serogroup 19 Contain β-N-Acetylglucosamine Residues” Ann. Neurol., 33: 243-247 (1993). |
Parkhill, et al. “The Genome Sequence of the Food-Borne Pathogen Campylobacter Jejuni Reveals Hypervariable Sequences,” Nature. vol. 403, pp. 665-668, (Feb. 10, 2000). |
Penner, et al., “Diversity of Lipopolysaccharide Structures in Campylobacter Jejuni,” The Journal of Infectious Diseases, vol. 176, No. 2, pp. S135-S138, (Dec. 1997). |
Prendergast, et al., “Lipopolysaccharides from Campylobacter Jejuni O:41 Strains Associated with Guillain-Barré Syndrome Exhibit Mimicry of GM1 Ganglioside,” Infection and Immunity, vol. 66, No. 8, pp. 3649-3677, (Aug. 1998). |
Preston, et al., “The Lipooligosaccharides of Pathogenic Gram-Negative Bacteria,” Critical Reviews in Microbiology, vol. 22, No. 3, pp. 139-180, (1998). |
Sabesan et al., “Combined Chemical and Enzymatic Synthesis of Sialyloligosaccharides and Characterization by 500-MHz 1H and C NMR Spectroscopy” J. Am. Chem. Soc., 108: 2068-2080 (1986). |
Salloway, et al., “Miller-Fisher Syndrome Associated with Campylobacter Jejuni Bearing Lipopolysaccharide Molecules that Mimic Human Ganglioside GD3,” Infection and Immunity, vol. 64, No. 8, pp. 2945-2949, (Aug. 1996). |
Wakarchuk, et al., “Functional Relationships of the Genetic Locus Encoding the Glycosyltransferase Enzymes Involved in Expression of the Lacto-N-neotetraose Terminal Lipopolysaccharide Structure in Neisseria meningitidis” J. Biol. Chem., 271: 19166-19173 (1996). |
Wood, et al., “Cloning, Mutation and Distribution of a Putative Lipopolysaccharide Biosynthesis Locus in Campylobacter Jejuni,” Microbiology, vol. 145, No. 2, pp. 379-388, (Feb. 1999). |